
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Continuous positive airway pressure (CPAP) therapy is a frequent treatment for obstructive sleep apnea. A CPAP device uses a hose linked to a mask or nosepiece to provide constant and consistent air pressure to assist you breathe while sleeping.Most experts and doctors agree that when used properly, they are safe and useful.
CBT is more successful than pharmaceutical sleep medications in treating chronic insomnia. CBT showed the biggest improvements in patients' ability to fall and stay asleep, and the advantages lasted even a year after therapy finished.
CPAP machines prevent sleep apnea-related breathing disruptions. These gadgets also reduce the negative symptoms of sleep apnea.
CPAP machine advantages include: improved sleep quality.CPAP machines treat sleep apnea by forcing oxygenated air into your airways via a mask and a tube.
The pressurised air keeps your airways from closing, allowing you to breathe normally while sleeping.
TheGlobal sleep therapy devices marketaccounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Philips Launches NightBalance for Positional Sleep Apnea.The Philips NightBalance is a prescription sleep position treatment device developed by Royal Philips for people with positional obstructive sleep apnea (OSA).
A mask-free alternative to current positional OSA therapies is NightBalance. The gadget is a positional treatment with clinical validation that employs moderate vibrations to persuade users to change their sleeping postures in order to aid in the prevention of apneas.
The brand-new positional OSA technology from Philips NightBalance includes wireless connectivity and a mobile app that tracks product usage and gives patients and doctors access to data through a cloud-based platform.
According to the business, several clinical studies have shown that Philips NightBalance provides positional OSA sufferers with an efficient non-invasive type of therapy.
The most recent study, "The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea," was funded by Philips and published in the Journal of Clinical Sleep Medicine.
It found that NightBalance had high adherence rates among positional OSA patients and was not inferior to continuous positive airway pressure (CPAP).
According to data, individuals with positional OSA thought NightBalance was more convenient, pleasant, and easier to use than alternative PAP treatment approaches.
In addition, patients receiving treatment for sleep position utilised the device for longer periods of time than those receiving PAP therapy; 74% of patients reported using NightBalance for more than four hours, compared to 64.9%.
Obstructive sleep apnea affects more than 100 million individuals globally today.Between 36% and 47% of those people are thought to have positional OSA, a kind of sleep apnea in which breathing problems are evident when lying on the back.2
Without therapy, positional OSA can result in restless nights and exhaustion, which lowers a patient's quality of life. For patients who have positional OSA and have tried other noninvasive treatment options without success, positional sleep apnea therapy, such as Philips NightBalance, is a viable option.
In the United States, United Kingdom, Austria, Germany, Switzerland, Belgium, the Netherlands, and Luxembourg, Philips NightBalance will be accessible with a prescription.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |